ReposiTrak, Inc.

ReposiTrak, Inc. announced a quarterly cash dividend of $0.02 per share, totaling $0.08 per share annually. The dividend is payable on or about August 14, 2026, to stockholders of record as of June 30, 2026. Subsequent dividends are expected to be paid within 45 days of each fiscal quarter end.

ReposiTrak, Inc. amended its Services Agreement with SPAR Group, Inc., allowing it to receive payment in cash, SPAR Group common stock, or a combination. On May 29, 2026, ReposiTrak elected to receive an outstanding balance of $2,325,000 in SPAR Group stock, resulting in the issuance of 3,190,569 shares at a deemed value of $0.728710119 per share.

ReposiTrak reported third fiscal quarter 2026 financial results, with operating income increasing 24% to $2.3 million and diluted EPS at $0.10. Revenue remained flat at $5.9 million, attributed to a temporary shift in traceability onboarding activity following an FDA compliance deadline extension. The company also announced filing two new patents for its Touchless Traceability™ solution and a new collaboration with SPAR Group to enhance in-store operational execution. ReposiTrak continued its capital return program, redeeming preferred shares, repurchasing common shares, and declaring a quarterly dividend.

ReposiTrak reported mixed financial results for the period ended March 31, 2026. While nine-month revenue grew 5.1% to $17.71 million and diluted EPS increased to $0.28, the third-quarter revenue saw a slight decrease year-over-year. The company also issued a $3.0 million unsecured note receivable to SPAR Marketing Force, Inc., with equity consideration and price protection provisions still pending issuance and valuation. Cash balances decreased due to operational activities, stock buybacks, and preferred stock redemptions.